微创心通-B(02160)股东将股票存入云锋证券 存仓市值6.51亿港元

智通财经
Jan 22

智通财经APP获悉,香港联交所最新资料显示,1月21日,微创心通-B(02160)股东将股票存入云锋证券,存仓市值6.51亿港元,占比9.56%。

微创心通公告,由集团联营公司4C Medical Technologies, Inc.(4C Medical)自主研发的AltaValveTM经导管二尖瓣置换(TMVR)医疗器械(AltaValveTM)的早期可行性研究一年随访结果正式公布。本次研究覆盖欧洲、美国、日本多中心,纳入患者30名,均为手术高风险、伴有症状性重度二尖瓣反流(MR)的患者,其中13名患者采用经心尖入路, 17名采用经房间隔入路。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10